Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis.
Fukasawa T, Yoshizaki A, Ebata S, Nakamura K, Saigusa R, Miura S, Yamashita T, Hirabayashi M, Ichimura Y, Taniguchi T, Asano Y, Shimizu H, Kazoe Y, Mawatari K, Kitamori T, Sato S. Fukasawa T, et al. Among authors: ebata s. Arthritis Rheumatol. 2017 Sep;69(9):1879-1890. doi: 10.1002/art.40164. Epub 2017 Aug 1. Arthritis Rheumatol. 2017. PMID: 28556548
Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells.
Yoshizaki A, Taniguchi T, Saigusa R, Fukasawa T, Ebata S, Numajiri H, Nakamura K, Yamashita T, Takahashi T, Toyama T, Asano Y, Tedder TF, Sato S. Yoshizaki A, et al. Among authors: ebata s. Ann Rheum Dis. 2016 Oct;75(10):1858-65. doi: 10.1136/annrheumdis-2015-207405. Epub 2015 Nov 13. Ann Rheum Dis. 2016. PMID: 26567180
Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.
Ebata S, Yoshizaki A, Fukasawa T, Nakamura K, Yamashita T, Miura S, Saigusa R, Ichimura Y, Takahashi T, Hirabayashi M, Taniguchi T, Akamata K, Asano Y, Sato S. Ebata S, et al. Scand J Rheumatol. 2017 May;46(3):247-252. doi: 10.1080/03009742.2016.1231341. Epub 2016 Nov 30. Scand J Rheumatol. 2017. PMID: 27900875 No abstract available.
116 results